Yumanity Therapeutics

Biotechnology company that transforms drug discovery for diseases caused by protein misfolding.

Launch date

2014

Employees

Market cap

Enterprise valuation

CAD17m (Public information from Dec 2022)

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	Dolby Family Ventures Altium Capital Management	N/A	-
Feb 2016	N/A	$51.0m	Series A
Feb 2016	N/A	N/A	IPO
Jun 2018	N/A	$31.1m	Post IPO Equity
Jun 2020	N/A	$21.6m	Series C
Dec 2020	Fidelity Investments Invus	$33.6m	Late VC
Dec 2022*	Kineta	N/A	Acquisition
Total Funding		CAD145m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Yumanity Therapeutics